SMYLS Multi-site Trial
NCT06035939 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 272
Last updated 2025-12-08
Summary
The purpose of this study is to find out whether a web-based intervention using a mobile app is helpful for teens and young adults with sickle cell disease (SCD) in learning how to care for and manage their symptoms.
Conditions
Interventions
- BEHAVIORAL
-
Voice Crisis Alert V2
The mHealth self-management intervention consists of the following components: 1) condition-specific electronic educational materials; 2) pain/symptom monitoring and tracking; 3) health history information documentation; 4) medication tracking; 5) secure messaging with a provider; 6) functioning monitoring and tracking; and 7) transmission of health information (graphs with recorded pain and functioning histories) to a provider.
- BEHAVIORAL
-
Electronic educational materials
The control arm will receive enhanced usual care, which will consist of usual educational materials distributed at the clinic plus a version of the intervention (Voice Crisis Alert V2) that only includes the electronic educational materials.
Sponsors & Collaborators
-
National Institute of Nursing Research (NINR)
collaborator NIH -
Medical University of South Carolina
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 14 Years
- Max Age
- 21 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2024-04-04
- Primary Completion
- 2027-07-31
- Completion
- 2028-01-31
Countries
- United States
Study Locations
More Related Trials
-
Delivering Patient-Facing Evidence-Based Guidelines Through mHealth to Adults With Sickle Cell Disease
NCT06919224 ·Status: RECRUITING ·Phase: NA
-
Empowering Adolescents and Young Adults With Sickle Cell Disease as Partners in Treatment Decision Making (EMPOWER-AYA)
NCT05383911 ·Status: RECRUITING ·Phase: NA
-
Sickle Cell Disease (SCD) Decision Aid
NCT03224429 ·Status: COMPLETED ·Phase: NA
-
A Sickle CEll Disease ComplicatioN Trial
NCT02604368 ·Status: UNKNOWN ·Phase: PHASE3
-
An mHealth Strategy to Improve Medication Adherence in Adolescents With Sickle Cell Disease
NCT04688411 ·Status: RECRUITING ·Phase: NA
-
Patient Centered Comprehensive Medication Adherence Management System in Patients With Sickle Cell Disease
NCT02371720 ·Status: COMPLETED ·Phase: NA
-
iCanCope With Sickle Cell Pain
NCT03201874 ·Status: COMPLETED ·Phase: NA
-
Laboratory-based Hypnosis Intervention on Pain Responsivity in Adolescents With Sickle Cell Disease
NCT02987725 ·Status: COMPLETED ·Phase: NA
-
CHOICES3: Sickle Cell Disease Parenting CHOICES
NCT05292781 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Parent Educational Program for Children With Sickle Cell Disease
NCT00860782 ·Status: COMPLETED ·Phase: NA
-
Pilot Evaluation of a Motivational Interviewing Intervention Targeting Adherence Behaviors in Youth With Sickle Cell Disease
NCT04877054 ·Status: COMPLETED ·Phase: NA
-
Building Adaptive Coping and Knowledge to Improve Daily Life
NCT04602728 ·Status: COMPLETED ·Phase: NA
-
Telemedicine for Children With Sickle Cell Disease
NCT05087303 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Patient-Provider Tools to Improve the Transition to Adult Care in Sickle Cell Disease
NCT02200510 ·Status: COMPLETED ·Phase: NA
-
FOCUS for Pediatric Sickle Cell Disease and Cancer
NCT04075877 ·Status: UNKNOWN ·Phase: NA
-
Cognitive Behavioral Therapy and Real-Time Pain Management Intervention for Sickle Cell Via Mobile Applications
NCT04419168 ·Status: COMPLETED ·Phase: NA
-
Study to Assess Safety and Impact of SelG1 With or Without Hydroxyurea Therapy in Sickle Cell Disease Patients With Pain Crises
NCT01895361 ·Status: COMPLETED ·Phase: PHASE2
-
Phase I/II Randomized Study of Hydroxyurea With or Without Clotrimazole in Patients With Sickle Cell Anemia
NCT00004492 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Testing the Sickle Cell Caregiver Collaboration for Child Development (SCCCD) Intervention
NCT06562439 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
A Brief Laboratory-Based Hypnosis Session for Pain in Sickle Cell Disease
NCT02620488 ·Status: COMPLETED ·Phase: NA
-
Minimizing Toxicity in HLA-identical Sibling Donor Transplantation for Children With Sickle Cell Disease
NCT03587272 ·Status: RECRUITING ·Phase: PHASE2
-
Use of Mobile Technology for Intensive Training in Medication Management
NCT02133560 ·Status: COMPLETED ·Phase: NA
-
A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of Oral GSK4172239D Compared With Placebo in Sickle Cell Disease Participants Aged 18 to 50 Years
NCT05660265 ·Status: TERMINATED ·Phase: PHASE1
-
Efficacy and Safety of Tocilizumab for Acute Chest Syndrome Treatment in Patients With Sickle Cell Disease
NCT06818266 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Dose-Escalation Study of SCD-101 in Sickle Cell Disease
NCT02380079 ·Status: UNKNOWN ·Phase: PHASE1